Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nardulli

Showing results (161-170 of 181) with videos related to

Pageof 19
Sort By:
Tumori|April 21, 2016
The European accreditation of Istituto Tumori Giovanni Paolo II of BariRosanna Lacalamita, Antonio Quaranta, Maria Pia Trisorio Liuzzi, et al.
Ebiomedicine|June 12, 2026
Seasonal vaccine-induced immunity shows preserved cross-reactivity to H3N2 subclade K in adultsAdria Wilson, Brian Lerman, Reima Ramsamooj, et al.
Medrxiv : the Preprint Server for Health Sciences|February 27, 2026
Seasonal vaccine-induced immunity shows preserved cross-reactivity to H3N2 subclade K in adultsAdria Wilson, Brian Lerman, Reima Ramsamooj, et al.
Expert Opinion on Pharmacotherapy|February 4, 2026
Belzutifan monotherapy and combination therapies in renal cell carcinoma: a clinical trial perspective from the ARON working groupConcetta Calabrò, Francesco Ciccimarra, Alessandro Rizzo, et al.
Vaccine|October 5, 2025
Comparing methods collecting mucosal secretions and detecting SARS-CoV-2 spike IgA in three laboratories across three countriesOscar Bladh, Katherina Aguilera, Salma Sheikh-Mohamed, et al.
Biorxiv : the Preprint Server for Biology|July 29, 2024
Dissecting human monoclonal antibody responses from mRNA- and protein-based XBB.1.5 COVID-19 monovalent vaccinesRaianna F Fantin, Jordan J Clark, Hallie Cohn, et al.
Frontiers in Medicine|November 11, 2024
Corrigendum: The molecular tumor board as a step in cancer patient management: a southern Italian experienceStefania Tommasi, Leonarda Maurmo, Alessandro Rizzo, et al.
Frontiers in Medicine|September 26, 2024
The molecular tumor board as a step in cancer patient management: a southern Italian experienceStefania Tommasi, Leonarda Maurmo, Alessandro Rizzo, et al.
The Lancet. Microbe|June 2, 2025
Mapping of human monoclonal antibody responses to XBB.1.5 COVID-19 monovalent vaccines: a B cell analysisRaianna F Fantin, Jordan J Clark, Hallie Cohn, et al.
Archives of Toxicology|June 14, 2025
Buccal micronucleus cytome assay to evaluate cyto-genotoxic effects of occupational exposure to antineoplastic drugs: application on a large sample size of workers furnished by an Italian network of oncological hospitalsC L Ursini, E Omodeo-Salè, G Di Gennaro, et al.
Pageof 19

Showing results (161-170 of 181) with videos related to

Sort By:
Pageof 19
Tumori|April 21, 2016
The European accreditation of Istituto Tumori Giovanni Paolo II of BariRosanna Lacalamita, Antonio Quaranta, Maria Pia Trisorio Liuzzi, et al.
Ebiomedicine|June 12, 2026
Seasonal vaccine-induced immunity shows preserved cross-reactivity to H3N2 subclade K in adultsAdria Wilson, Brian Lerman, Reima Ramsamooj, et al.
Medrxiv : the Preprint Server for Health Sciences|February 27, 2026
Seasonal vaccine-induced immunity shows preserved cross-reactivity to H3N2 subclade K in adultsAdria Wilson, Brian Lerman, Reima Ramsamooj, et al.
Expert Opinion on Pharmacotherapy|February 4, 2026
Belzutifan monotherapy and combination therapies in renal cell carcinoma: a clinical trial perspective from the ARON working groupConcetta Calabrò, Francesco Ciccimarra, Alessandro Rizzo, et al.
Vaccine|October 5, 2025
Comparing methods collecting mucosal secretions and detecting SARS-CoV-2 spike IgA in three laboratories across three countriesOscar Bladh, Katherina Aguilera, Salma Sheikh-Mohamed, et al.
Biorxiv : the Preprint Server for Biology|July 29, 2024
Dissecting human monoclonal antibody responses from mRNA- and protein-based XBB.1.5 COVID-19 monovalent vaccinesRaianna F Fantin, Jordan J Clark, Hallie Cohn, et al.
Frontiers in Medicine|November 11, 2024
Corrigendum: The molecular tumor board as a step in cancer patient management: a southern Italian experienceStefania Tommasi, Leonarda Maurmo, Alessandro Rizzo, et al.
Frontiers in Medicine|September 26, 2024
The molecular tumor board as a step in cancer patient management: a southern Italian experienceStefania Tommasi, Leonarda Maurmo, Alessandro Rizzo, et al.
The Lancet. Microbe|June 2, 2025
Mapping of human monoclonal antibody responses to XBB.1.5 COVID-19 monovalent vaccines: a B cell analysisRaianna F Fantin, Jordan J Clark, Hallie Cohn, et al.
Archives of Toxicology|June 14, 2025
Buccal micronucleus cytome assay to evaluate cyto-genotoxic effects of occupational exposure to antineoplastic drugs: application on a large sample size of workers furnished by an Italian network of oncological hospitalsC L Ursini, E Omodeo-Salè, G Di Gennaro, et al.
Pageof 19